Ourania Tatsis

EVP, Chief Reg. & Quality Off.

Ourania Tatsis (EVP, Chief Reg. & Quality Off.) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Vertex Pharmaceuticals Incorporated (VRTX). The largest single filing was $2.1M of VRTX (4,500 sh × $474.99, as filed), executed Jan 7.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 7 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$6.5M

shares × price, as filed

Last traded

Jul 2

Filed Jul 7

Median ADV $756.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $10.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names

VRTX Vertex Pharmaceuticals Incorporated VRTX · 0 buys · 13 sells 13 filings

Recent filings

VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $787K
1,500 sh × $524.99
Exec Jul 2
Filed Jul 7 · 4:15 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $126K
260 sh × $486.35
Exec Feb 25
Filed Feb 26 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $472K
977 sh across 2 lots
Exec Feb 17
Filed Feb 19 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $750K
1,500 sh × $499.99
Exec Feb 13
Filed Feb 18 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $215K
466 sh × $460.43
Exec Feb 11
Filed Feb 12 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $2.1M
4,500 sh × $474.99
Exec Jan 7
Filed Jan 9 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $2.0M
4,500 sh × $449.99
Exec Dec 3 2025
Filed Dec 5 2025 · 5:30 PM ET VRTXSALE Vertex Pharmaceuticals Incorporated View filing → $1.6M
3,242 sh × $499.99
Exec Mar 10 2025
Filed Mar 12 2025 · 5:30 PM ET More filings →